These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24009107)

  • 21. Potential selection of LMP1 variants in nasopharyngeal carcinoma.
    Edwards RH; Sitki-Green D; Moore DT; Raab-Traub N
    J Virol; 2004 Jan; 78(2):868-81. PubMed ID: 14694118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Structural and functional features of Epstein-Barr virus LMP-1 gene in patients with anaplastic carcinoma of the nasopharynx in Russia].
    Gurtsevich VE; Shcherbak LN; Novikova EV; Hahn P; Belousova NV; Arkhipov VV; Grasser FA; Müller-Lantzsch N; Pavlish OA
    Vestn Ross Akad Med Nauk; 2002; (1):53-9. PubMed ID: 11882974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epstein-Barr virus (EBV) in Russia: infection of the population and analysis of the LMP1 gene variants in patients with EBV-associated pathologies and healthy individuals].
    Goncharova EV; Senyuta NB; Smirnova KV; Shcherbak LN; Gurtsevich VE
    Vopr Virusol; 2015; 60(2):11-7. PubMed ID: 26182651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies.
    da Costa VG; Marques-Silva AC; Moreli ML
    Syst Rev; 2015 Apr; 4():46. PubMed ID: 25927427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma.
    Li DJ; Bei JX; Mai SJ; Xu JF; Chen LZ; Zhang RH; Yu XJ; Hong MH; Zeng YX; Kang T
    J Med Virol; 2009 Jul; 81(7):1253-60. PubMed ID: 19475622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia.
    Burrows JM; Bromham L; Woolfit M; Piganeau G; Tellam J; Connolly G; Webb N; Poulsen L; Cooper L; Burrows SR; Moss DJ; Haryana SM; Ng M; Nicholls JM; Khanna R
    J Virol; 2004 Jul; 78(13):7131-7. PubMed ID: 15194789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China.
    Zhang XS; Song KH; Mai HQ; Jia WH; Feng BJ; Xia JC; Zhang RH; Huang LX; Yu XJ; Feng QS; Huang P; Chen JJ; Zeng YX
    Cancer Lett; 2002 Feb; 176(1):65-73. PubMed ID: 11790455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of the Taiwan variant of the Epstein-Barr virus in nasopharyngeal carcinoma patients and normal individuals.
    Shu CH; Tu TY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):288-93. PubMed ID: 10820907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections.
    Tan EL; Peh SC; Sam CK
    J Med Virol; 2003 Feb; 69(2):251-7. PubMed ID: 12683415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Epstein-Barr virus type 1 nuclear antigen 3C sequence patterns of nasopharyngeal and gastric carcinomas in northern China.
    Wu G; Wang Y; Chao Y; Jia Y; Zhao C; Luo B
    Arch Virol; 2012 May; 157(5):845-53. PubMed ID: 22302288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients.
    Dardari R; Khyatti M; Cordeiro P; Odda M; ElGueddari B; Hassar M; Menezes J
    Int J Cancer; 2006 Apr; 118(8):1977-83. PubMed ID: 16287066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients.
    Hadhri-Guiga B; Khabir AM; Mokdad-Gargouri R; Ghorbel AM; Drira M; Daoud J; Frikha M; Jlidi R; Gargouri A
    Virus Res; 2006 Jan; 115(1):24-30. PubMed ID: 16154221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [DNA cloning and partial sequence analysis of EBV LMP1 gene isolated from human nasopharyngeal carcinoma cell line SUNE1].
    Chen Y; Guo H; Cao H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Sep; 13(3):217-21. PubMed ID: 12569749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma.
    Hu LF; Zabarovsky ER; Chen F; Cao SL; Ernberg I; Klein G; Winberg G
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2399-409. PubMed ID: 1681026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma.
    Hu L; Troyanovsky B; Zhang X; Trivedi P; Ernberg I; Klein G
    Cancer Res; 2000 Oct; 60(19):5589-93. PubMed ID: 11034108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LMP1 strain variants: biological and molecular properties.
    Mainou BA; Raab-Traub N
    J Virol; 2006 Jul; 80(13):6458-68. PubMed ID: 16775333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mutations of the Epstein-Barr virus LMP1 gene mutations in Russian patients with lymphoid pathology and healthy individuals].
    Pavlish OA; Diduk SV; Smirnova KV; Shcherbak LN; Goncharova EV; Shalginskikh NA; Arkhipov VV; Kichigina MIu; Stepina VN; Belousova NV; Osmanov EA; Iakovleva LS; Gurtsevich VE
    Vopr Virusol; 2008; 53(1):10-6. PubMed ID: 18318128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The LMP1 gene isolated from Russian nasopharyngeal carcinoma has no 30-bp deletion.
    Hahn P; Novikova E; Scherback L; Janik C; Pavlish O; Arkhipov V; Nicholls J; Müller-Lantzsch N; Gurtsevitch V; Grässer FA
    Int J Cancer; 2001 Mar; 91(6):815-21. PubMed ID: 11275985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.
    See HS; Yap YY; Yip WK; Seow HF
    World J Surg Oncol; 2008 Feb; 6():18. PubMed ID: 18275617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.